Los Angeles Times: COVID-19 clinical trial
Publication mentions UC's efforts to study a drug used in organ transplantation to treat the virus
In a race to find medicines that can tame the coronavirus and treat patients with COVID-19, researchers are scouring the formulary of available drugs and chemical compounds in hopes of finding something they could put to work immediately.
As a result, dozens of existing medicines have been waved through to clinical trials in record time.
Among those medicines is an immune-suppressing drug, called sirolimus, which is being studied in a novel clinical trial at UC. Sirolimus is used to reduce rejection episodes in organ transplant patients and to treat lymphangioleiomyomatosis, or LAM, a rare lung disease. UC researchers were pioneers in discovering this rare lung disease as well as finding an effective treatment for it.
Dr. Nishant Gupta is leading the sirolimus trial at UC, and he received a pilot grant to help execute it.
Read more about clinical trials being conducted at UC.
Featured photo/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
State continues support for the Ohio Cyber Range
June 5, 2026
The Ohio Cyber Range Institute at the University of Cincinnati recently received $227,000 from the Ohio Controlling Board., reported Local 12 News. The OCRI manages the Ohio Cyber Range on behalf of the state. It is a statewide, collaborative network that supports cybersecurity programs across Ohio.
UC alumni-led band The National named among greatest living American songwriters
June 4, 2026
UC-connected band The National, co-founded by DAAP alumni, has been named to The New York Times Magazine readers’ list of the 100 Greatest Living American Songwriters.